M.D. Sass LLC Purchases New Stake in AMETEK, Inc. $AME

M.D. Sass LLC acquired a new position in shares of AMETEK, Inc. (NYSE:AMEFree Report) during the second quarter, HoldingsChannel.com reports. The firm acquired 333,370 shares of the technology company’s stock, valued at approximately $80,656,000. AMETEK makes up approximately 5.3% of M.D. Sass LLC’s portfolio, making the stock its 5th biggest holding.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. boosted its holdings in AMETEK by 6.2% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 487,238 shares of the technology company’s stock valued at $101,901,000 after purchasing an additional 28,621 shares during the last quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund acquired a new stake in shares of AMETEK during the 4th quarter worth approximately $1,027,000. Fifth Third Bancorp raised its position in shares of AMETEK by 1,060.3% during the 1st quarter. Fifth Third Bancorp now owns 82,948 shares of the technology company’s stock valued at $17,781,000 after buying an additional 75,799 shares during the period. Wescott Financial Advisory Group LLC acquired a new position in AMETEK in the fourth quarter valued at approximately $1,122,000. Finally, Investment Management Corp VA ADV acquired a new position in AMETEK in the fourth quarter valued at approximately $496,000. Institutional investors and hedge funds own 87.43% of the company’s stock.

AMETEK Stock Down 1.6%

AMETEK stock opened at $250.21 on Wednesday. The company has a market capitalization of $57.35 billion, a PE ratio of 36.58, a price-to-earnings-growth ratio of 3.26 and a beta of 0.98. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.76 and a current ratio of 1.21. AMETEK, Inc. has a fifty-two week low of $179.24 and a fifty-two week high of $261.16. The firm has a 50 day moving average price of $239.95 and a 200 day moving average price of $231.70.

AMETEK (NYSE:AMEGet Free Report) last released its quarterly earnings results on Tuesday, August 4th. The technology company reported $2.09 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.10. AMETEK had a return on equity of 16.93% and a net margin of 20.04%.The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $1.95 billion. During the same period in the prior year, the firm earned $1.78 earnings per share. The firm’s revenue was up 15.0% compared to the same quarter last year. AMETEK has set its Q3 2026 guidance at 2.080-2.100 EPS and its FY 2026 guidance at 8.200-8.300 EPS. Research analysts expect that AMETEK, Inc. will post 8.33 earnings per share for the current year.

AMETEK Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a $1.36 annualized dividend and a yield of 0.5%. AMETEK’s dividend payout ratio is presently 19.88%.

Insider Buying and Selling

In related news, insider David F. Hermance sold 6,608 shares of the firm’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of $254.00, for a total transaction of $1,678,432.00. Following the completion of the transaction, the insider directly owned 42,509 shares in the company, valued at $10,797,286. This trade represents a 13.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.54% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Truist Financial raised their target price on AMETEK from $303.00 to $316.00 and gave the stock a “buy” rating in a research note on Thursday, August 6th. Morgan Stanley upped their price target on AMETEK from $235.00 to $245.00 and gave the company an “equal weight” rating in a research note on Friday, July 10th. Seaport Research Partners reissued a “buy” rating and set a $290.00 price objective on shares of AMETEK in a research report on Wednesday, August 5th. DA Davidson boosted their price objective on shares of AMETEK from $265.00 to $285.00 and gave the company a “buy” rating in a report on Wednesday, August 5th. Finally, KeyCorp upped their target price on shares of AMETEK from $260.00 to $295.00 and gave the company an “overweight” rating in a research report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $266.80.

Read Our Latest Stock Report on AMETEK

About AMETEK

(Free Report)

AMETEK, Inc is a global manufacturer of electronic instruments and electromechanical devices that serves a broad range of industries. Headquartered in Berwyn, Pennsylvania, the company designs and produces precision instruments, electronic measurement devices, specialty sensors, and electric motors and motion control systems. Its product portfolio includes analytical and monitoring instruments, calibration equipment, power supplies, embedded electronics, and industrial motors and drives used for critical applications.

The company operates through two primary business platforms — an electronic instruments group focused on analytical, test and measurement and sensor products, and an electromechanical group that supplies motors, actuators, and related power and motion solutions.

Featured Articles

Want to see what other hedge funds are holding AME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AMETEK, Inc. (NYSE:AMEFree Report).

Institutional Ownership by Quarter for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.